Cantitate/Preț
Produs

Human-Based Systems for Translational Research: RSC Drug Discovery, cartea 41

Geny Groothius Editat de Robert Coleman, David Fox
en Limba Engleză Hardback – 8 dec 2014
This book provides a detailed history and discussion of the use of human tissues as an alternative to animal-based testing for assessing the efficacy and safety of new medicines.
Citește tot Restrânge

Din seria RSC Drug Discovery

Preț: 112012 lei

Preț vechi: 117908 lei
-5% Nou

Puncte Express: 1680

Preț estimativ în valută:
21437 22267$ 17806£

Cartea se retipărește

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781849738255
ISBN-10: 1849738254
Pagini: 305
Dimensiuni: 165 x 239 x 20 mm
Greutate: 0.54 kg
Editura: Royal Society Of Chemistry
Seria RSC Drug Discovery


Textul de pe ultima copertă

This book provides a history and discussion of the use of human tissues as an alternative to animal-based testing for assessing the efficacy and safety of new medicines. Beginning by providing a historical background to animal-based testing, this text then describes in detail the issues relating to access to human cells and tissue and the rules and regulations governing their use. The book illustrates what is currently possible in humanising medicines research and development, and suggests more rational and reliable means of developing safe and effective drugs for the future than those on which we currently rely.
Early chapters establish the need to generate more data in human-derived test systems, and the need for resources such as tissue banks and standardised processes whilst highlighting the barriers that have prevented such developments so far. Subsequent chapters explore the alternatives to current animal toxicology studies, including stem cells and computational models, with balanced views of the technical challenges and opportunities these offer. In addition, useful information on computational methods and pharmacokinetics are included.
This book is an essential read for anyone engaged in translational drug discovery who wishes to consolidate their understanding and broaden their awareness of the key issues involved in accessing primary human tissue and the advantages of doing so.